info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0141427 |
| CAS No | NA |
| Mol.F. | C19H19N5O |
| Mol.Wt. | 333.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141428 |
| CAS No | NA |
| Mol.F. | C46H42Cl4N10O8 |
| Mol.Wt. | 1000.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141429 |
| CAS No | NA |
| Mol.F. | C39H28Cl4N8O8 |
| Mol.Wt. | 878.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141430 |
| CAS No | NA |
| Mol.F. | C21H25FN4O |
| Mol.Wt. | 368.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141431 |
| CAS No | NA |
| Mol.F. | C31H28BrN3O3 |
| Mol.Wt. | 570.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141432 |
| CAS No | NA |
| Mol.F. | C31H29N3O3 |
| Mol.Wt. | 491.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141433 |
| CAS No | NA |
| Mol.F. | C14H14N2O2 |
| Mol.Wt. | 242.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141434 |
| CAS No | NA |
| Mol.F. | C11H13ClN4O5S3 |
| Mol.Wt. | 412.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141435 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O3 |
| Mol.Wt. | 324.8 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141436 |
| CAS No | NA |
| Mol.F. | C16H17N3O5 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141437 |
| CAS No | NA |
| Mol.F. | C16H16N4O6 |
| Mol.Wt. | 360.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141438 |
| CAS No | NA |
| Mol.F. | C13H14N6O5S2 |
| Mol.Wt. | 398.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141439 |
| CAS No | NA |
| Mol.F. | C22H28N6O7S |
| Mol.Wt. | 520.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141440 |
| CAS No | NA |
| Mol.F. | C50H59N9O19S4 |
| Mol.Wt. | 1218.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141441 |
| CAS No | NA |
| Mol.F. | C31H36N8O5 |
| Mol.Wt. | 600.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141442 |
| CAS No | NA |
| Mol.F. | C31H35N9O6 |
| Mol.Wt. | 629.7 |
| INV STATUS | CUSTOM SYNTHESIS |
